ipamorelin do – Research Peptide Ipamorelin: The Ultimate Growth Hormone-Releasing

Dual-peptide secretagogue formulation for GH axis research CJC-1295: studied for GHRH signal amplification and extended half-life Ipamorelin: selective ghrelin-receptor agonist with minimal cortisol/prolactin effects Balanced delivery of both peptides in each application Pre-filled pen format for precise, repeatable volume delivery in research applications What Researchers Say Frequently Asked Questions A dual formulation of Ipamorelin (a selective GHSR-1a agonist) and CJC-1295 (a GHRH analogue), both studied in growth-hormone-axis research

A: Ipamorelin is effective while it is being administered

It tells the body to release its own growth hormone in short, natural pulses

Multiple RCTs document its efficacy in reducing visceral fat by 20% over 26 weeks